About MTaI
MTaI is an association of research-based medical technology companies who have made remarkable investments by setting up large number of R&D centres and manufacturing plants in India. MTaI represents a wide spectrum of the medical device and equipment industry with global experience in innovation and manufacturing.
All the time stressing on the three hallmarks of healthcare – Quality, Consistency and Patient Safety, we want to be a responsible voice of the industry. We are committed to improving access to affordable and quality healthcare for patients… Read More
MTaI-PwC Whitepaper
Whitepaper on the impact of COVID-19 on the MedTech & Healthcare Industry in India
Click here for details.
Union Budget: Lower custom duty on import of medical devices, say experts
New Delhi, July 18 (IANS) Ahead of the upcoming Union Budget 2024-25, experts on Thursday called on lowering customs duty on import of global medical devices.Finance Minister Nirmala Sitharaman is expected to present the Union Budget 2024 on July 23. Speaking to IANS,...
Government eases rules for global sourcing of medical gear
Allows global tenders for procurement of 354 medical deveices amid concerns over lack of domestic options The government has allowed global tenders to be floated for procurement of 354 medical devices after the health ministry raised concerns over the lack of domestic...
Navigating the Complexities of Medical Device Pricing: Insights from Pavan Choudary
In an exclusive interview with Arunima Rajan, Pavan Choudary, Chairman of the Medical Technology Association of India (MTaI), discusses the pricing framework for medical devices, shedding light on its critical aspects and implications for the industry. What are the...
Can price control create treatment Bias?
The article explores the complex repercussions of price controls in healthcare and the emerging evidence of unintended consequences. Levitt and Dubner in their book Freakonomics quote a medical study which found that obstetricians in areas with declining birth rates...
Medical device bodies welcome CDSCO order on self-reporting adverse effects
Medical device associations have flagged the need to ensure systematic reviews while welcoming the Central Drugs Standard Control Organisation’s (CDSCO) move to urge all licensed medical device manufacturers to use the Materiovigilance Programme of India (MvPI) portal...
Medical device companies get a three-month extension for licences
The Central Drugs Standard Control Organization (CDSCO) has granted an extension of three months to existing manufacturers and importers of high-risk medical devices if they have applied for licences before September 30, 2023. “It has been decided that, in case, if an...
